Myriad Genetics

MAY 20, 2025

The majority of these patients (54%) agree that genetic testing for mental health medications (known as pharmacogenomic or PGx testing) could reduce these concerns. The majority of these patients (54%) agree that genetic testing for mental health medications (known as pharmacogenomic or PGx testing) could reduce these concerns.

Mental Health 52

Mental Health Diagnose Medical Patients 52

FDA Law Blog

JULY 10, 2023

Lenz, Principal Medical Device Regulation Expert — It takes a significant amount of time, cost, and effort to prepare a premarket notification 510(k) submission. In this blog post, we will first briefly outline the procedural steps in the 510(k) review process for medical devices. By Philip Won & Adrienne R.

Provider 75

Provider IT Engineering Medical 75

Permanente Medicine

JUNE 25, 2025

By building an integrated, patient-centered colorectal cancer screening program, we doubled screening rates, cut deaths by 50%, and made major strides in closing racial disparities in outcomes. The approach was simple: consistently alert patients that it’s time to get screened and make getting screened as easy as possible.

Screening 52

Screening Preventive Care Preventative Care Patient-Centered 52

GeriPal

APRIL 18, 2024

Alex: In 2019 … You wrote two viewpoints about AI recently in JAMA, relatively recently. I guess, 2019, and then, one again about last month or so. Then, it was like, well, it does as well as, and now, better than humans passing the medical boards, passing the law boards, doing great on the SAT, all that stuff. Eric: Yeah.

IT 139

IT Electronics Patients Healthcare 139